Manager firm
Janus Henderson
Manager(s)
David Smith, Andrew Jones
Structure
UK Equity & Bond Income
AIC sector
UK Equity & Bond Income
Base currency
GBP
Launched
1989-01-01
Latest factsheet
2026-10-31
Snapshot date
2025-08-31
Manager firm
Janus Henderson
Manager(s)
David Smith, Andrew Jones
Structure
UK Equity & Bond Income
AIC sector
UK Equity & Bond Income
Base currency
GBP
Launched
1989-01-01
Latest factsheet
2026-10-31
Snapshot date
2025-08-31
Share price
202.07p
NAV / share
213.00p2026-11-19
Premium / discount
-5.13%
Fund size
£370m
OCF
0.68%
Performance fee
—
Gearing
20.00%
Dividend yield
5.40%
| Period | Return | Benchmark | Vs |
|---|---|---|---|
| 1m | 2.0% | 1.0% | +1.0pp |
| 3m | 1.9% | -0.1% | +2.0pp |
| 6m | 8.3% | 4.7% | +3.6pp |
| 1y | 17.6% | 11.2% | +6.4pp |
| 3y | 75.8% | 52.3% | +23.5pp |
| 5y | 68.1% | 50.8% | +17.3pp |
| 10y | 103.3% | 95.5% | +7.8pp |
| # | Holding | Sector | Country | Weight |
|---|---|---|---|---|
| 1 | British American Tobacco | — | — | 5.1% |
| 2 | BP | — | — | 4.1% |
| 3 | Shell | — | — | 4.0% |
| 4 | HSBC | — | — | 3.9% |
| 5 | GSK | — | — | 3.3% |
| 6 | RELX | — | — | 3.1% |
| 7 | Imperial Brands | — | — | 2.6% |
| 8 | Standard Life | — | — | 2.6% |
| 9 | Lloyds Banking Group | — | — | 2.5% |
| 10 | Reckitt Benckiser Group | — | — | 2.3% |
| UK | 79.2% | |
| Fixed Interest | 9.3% | |
| France | 4.6% | |
| Netherlands | 3.5% | |
| Germany | 1.2% | |
| Cash near Cash | 1.1% | |
| Sweden | 1.0% | |
| Australia | 0.8% | |
| USA | 0.8% | |
| Guernsey | 0.6% |
| Portfolio yield | 5.29% |
| Unlisted holdings | — |
| Cash & equivalents | 1.06% |
| Total assets | £402.3m |
| Revenue reserves | £0 |
| Net gearing | 19.90% |
| Gross gearing | 21.20% |
| Net cash | £0 |
| Gearing range (from) | 0.00% |
| Gearing range (to) | 40.00% |
| Shares in issue | 170,115,545 |
| Shares issued | 0 |
| Shares purchased | 449,256 |
| Treasury shares | 2,026,155 |
UK equities outperformed global equity markets in October. The FTSE All-Share Index rose 1.1% as global equities declined amid growing concerns over the scale, financing and potential returns from AI-related investment. The large-cap FTSE 100 Index rose 1.3% during the month, outperforming the mid-cap FTSE 250 Index which fell 0.1%. The UK market benefited from its relatively low exposure to technology and greater weighting in energy and typically more defensive sectors, which performed comparatively well as investors shifted away from growth-style stocks. Domestically, the UK economy remained resilient, with second-quarter GDP growth being revised higher, and a modest expansion in August. Meanwhile, business activity reached an eight-month high. However, inflation rose to 3.5% as higher fuel prices added to cost pressures. UK gilt yields initially rose (prices fell) alongside the yields of global bond markets. However, they subsequently declined (prices rose) as weaker risk appetite increased demand for government bonds, and as the Autumn Budget provided reassurance over the government's commitment to fiscal discipline. The best-performing sectors included technology, which was led by a recovery in UK technology stocks which investors had previously deemed to be at risk from AI. This was followed by energy and consumer staples stocks. Shares in the basic materials, financial and industrial sectors lagged. The equity holdings in Imperial Brands, British American Tobacco and RELX contributed to performance. Shares in Imperial Brands outperformed following a reassuring trading update, with robust pricing, strong cash generation and the announcement of a further £1.5 billion share buyback supporting sentiment towards the company. British American Tobacco's shares also benefited from a shift towards more defensive, cash-generative businesses during the month. RELX's shares performed well following a strong trading update which showed robust underlying revenue growth and continued momentum across its higher-growth analytics and decision-tools businesses (including its AI-enabled products). The holding in Whitbread also contributed to performance following an encouraging interim-results announcement, with Premier Inn continuing to outperform the wider UK hotel market. Its shares were further supported by the UK Budget, which reduced the expected increase in business rates. The equity positioning in AstraZeneca and Shell detracted from performance. While we own both companies, our holdings are smaller than their respective weightings in the benchmark, meaning their strong share price performance detracted from relative returns. Shares in AstraZeneca benefited from strong results, with earnings growth and positive drug-development progress, while Shell's shares were supported by higher oil prices, record refining margins and a larger share buyback. The holding in Aberdeen also detracted from performance as the shares fell despite the company announcing a broadly resilient trading update, with continued outflows from parts of the asset management business weighing on investor sentiment. The main portfolio activity during the month was the sale of Bodycote following its agreed takeover. We reinvested the proceeds into the bond portfolio, taking advantage of the attractive yields available following the rise in bond yields earlier in the month. Purchases included bonds issued by RAC, PureGym and Bank of Ireland, adding to the portfolio's income while maintaining diversified exposure across issuers. Global markets have become more volatile as investors question the scale and potential returns from AI investment, prompting a shift away from higher-valued US technology and cyclical stocks (those firms typically more dependent on economic growth to do well) towards more defensive areas of the market. Inflation has also risen as higher energy prices have fed through, although there are signs that underlying pressures are more subdued and inflation could peak below current Bank of England (BoE) forecasts. Therefore, interest rates may not need to rise as far as markets expect, in our view. In the UK, economic growth has remained more resilient than expected, supported by healthy consumer and corporate balance sheets and a well-capitalised banking system, while the recent Budget created no significant new headwinds. Against this backdrop, UK equities remain attractive to us relative to both history and overseas equity markets, while the recent broadening of performance beyond the largest companies is encouraging. We continue to take a balanced approach, owning resilient businesses alongside what we see as attractively valued cyclical companies.
| 2026-09-30 | PDF → |
| 2026-08-31 | PDF → |
| 2026-07-31 | PDF → |
| 2026-07-31 | PDF → |
| 2026-06-30 | PDF → |
| 2026-05-31 | PDF → |
| 2026-04-30 | PDF → |
| 2026-03-31 | PDF → |
| 2026-02-28 | PDF → |
| 2026-02-28 | PDF → |
| 2026-01-31 | PDF → |
| 2026-01-31 | PDF → |
| 2025-12-31 | PDF → |
| 2025-12-31 | PDF → |
| 2025-11-30 | PDF → |
| 2025-11-30 | PDF → |
| 2025-10-31 | PDF → |
| 2025-10-31 | PDF → |
| 2025-09-30 | PDF → |
| 2025-09-30 | PDF → |
| 2025-08-31 | PDF → |
| 2025-08-31 | PDF → |
| 2025-07-31 | PDF → |
Manager firm
Janus Henderson
Manager(s)
David Smith, Andrew Jones
Structure
UK Equity & Bond Income
AIC sector
UK Equity & Bond Income
Base currency
GBP
Launched
1989-01-01
Latest factsheet
2026-10-31
Snapshot date
2025-08-31
Share price
202.07p
NAV / share
213.00p2026-11-19
Premium / discount
-5.13%
Fund size
£370m
OCF
0.68%
Performance fee
—
Gearing
20.00%
Dividend yield
5.40%
| Period | Return | Benchmark | Vs |
|---|---|---|---|
| 1m | 2.0% | 1.0% | +1.0pp |
| 3m | 1.9% | -0.1% | +2.0pp |
| 6m | 8.3% | 4.7% | +3.6pp |
| 1y | 17.6% | 11.2% | +6.4pp |
| 3y | 75.8% | 52.3% | +23.5pp |
| 5y | 68.1% | 50.8% | +17.3pp |
| 10y | 103.3% | 95.5% | +7.8pp |
| # | Holding | Sector | Country | Weight |
|---|---|---|---|---|
| 1 | British American Tobacco | — | — | 5.1% |
| 2 | BP | — | — | 4.1% |
| 3 | Shell | — | — | 4.0% |
| 4 | HSBC | — | — | 3.9% |
| 5 | GSK | — | — | 3.3% |
| 6 | RELX | — | — | 3.1% |
| 7 | Imperial Brands | — | — | 2.6% |
| 8 | Standard Life | — | — | 2.6% |
| 9 | Lloyds Banking Group | — | — | 2.5% |
| 10 | Reckitt Benckiser Group | — | — | 2.3% |
| UK | 79.2% | |
| Fixed Interest | 9.3% | |
| France | 4.6% | |
| Netherlands | 3.5% | |
| Germany | 1.2% | |
| Cash near Cash | 1.1% | |
| Sweden | 1.0% | |
| Australia | 0.8% | |
| USA | 0.8% | |
| Guernsey | 0.6% |
| Portfolio yield | 5.29% |
| Unlisted holdings | — |
| Cash & equivalents | 1.06% |
| Total assets | £402.3m |
| Revenue reserves | £0 |
| Net gearing | 19.90% |
| Gross gearing | 21.20% |
| Net cash | £0 |
| Gearing range (from) | 0.00% |
| Gearing range (to) | 40.00% |
| Shares in issue | 170,115,545 |
| Shares issued | 0 |
| Shares purchased | 449,256 |
| Treasury shares | 2,026,155 |
UK equities outperformed global equity markets in October. The FTSE All-Share Index rose 1.1% as global equities declined amid growing concerns over the scale, financing and potential returns from AI-related investment. The large-cap FTSE 100 Index rose 1.3% during the month, outperforming the mid-cap FTSE 250 Index which fell 0.1%. The UK market benefited from its relatively low exposure to technology and greater weighting in energy and typically more defensive sectors, which performed comparatively well as investors shifted away from growth-style stocks. Domestically, the UK economy remained resilient, with second-quarter GDP growth being revised higher, and a modest expansion in August. Meanwhile, business activity reached an eight-month high. However, inflation rose to 3.5% as higher fuel prices added to cost pressures. UK gilt yields initially rose (prices fell) alongside the yields of global bond markets. However, they subsequently declined (prices rose) as weaker risk appetite increased demand for government bonds, and as the Autumn Budget provided reassurance over the government's commitment to fiscal discipline. The best-performing sectors included technology, which was led by a recovery in UK technology stocks which investors had previously deemed to be at risk from AI. This was followed by energy and consumer staples stocks. Shares in the basic materials, financial and industrial sectors lagged. The equity holdings in Imperial Brands, British American Tobacco and RELX contributed to performance. Shares in Imperial Brands outperformed following a reassuring trading update, with robust pricing, strong cash generation and the announcement of a further £1.5 billion share buyback supporting sentiment towards the company. British American Tobacco's shares also benefited from a shift towards more defensive, cash-generative businesses during the month. RELX's shares performed well following a strong trading update which showed robust underlying revenue growth and continued momentum across its higher-growth analytics and decision-tools businesses (including its AI-enabled products). The holding in Whitbread also contributed to performance following an encouraging interim-results announcement, with Premier Inn continuing to outperform the wider UK hotel market. Its shares were further supported by the UK Budget, which reduced the expected increase in business rates. The equity positioning in AstraZeneca and Shell detracted from performance. While we own both companies, our holdings are smaller than their respective weightings in the benchmark, meaning their strong share price performance detracted from relative returns. Shares in AstraZeneca benefited from strong results, with earnings growth and positive drug-development progress, while Shell's shares were supported by higher oil prices, record refining margins and a larger share buyback. The holding in Aberdeen also detracted from performance as the shares fell despite the company announcing a broadly resilient trading update, with continued outflows from parts of the asset management business weighing on investor sentiment. The main portfolio activity during the month was the sale of Bodycote following its agreed takeover. We reinvested the proceeds into the bond portfolio, taking advantage of the attractive yields available following the rise in bond yields earlier in the month. Purchases included bonds issued by RAC, PureGym and Bank of Ireland, adding to the portfolio's income while maintaining diversified exposure across issuers. Global markets have become more volatile as investors question the scale and potential returns from AI investment, prompting a shift away from higher-valued US technology and cyclical stocks (those firms typically more dependent on economic growth to do well) towards more defensive areas of the market. Inflation has also risen as higher energy prices have fed through, although there are signs that underlying pressures are more subdued and inflation could peak below current Bank of England (BoE) forecasts. Therefore, interest rates may not need to rise as far as markets expect, in our view. In the UK, economic growth has remained more resilient than expected, supported by healthy consumer and corporate balance sheets and a well-capitalised banking system, while the recent Budget created no significant new headwinds. Against this backdrop, UK equities remain attractive to us relative to both history and overseas equity markets, while the recent broadening of performance beyond the largest companies is encouraging. We continue to take a balanced approach, owning resilient businesses alongside what we see as attractively valued cyclical companies.
| 2026-09-30 | PDF → |
| 2026-08-31 | PDF → |
| 2026-07-31 | PDF → |
| 2026-07-31 | PDF → |
| 2026-06-30 | PDF → |
| 2026-05-31 | PDF → |
| 2026-04-30 | PDF → |
| 2026-03-31 | PDF → |
| 2026-02-28 | PDF → |
| 2026-02-28 | PDF → |
| 2026-01-31 | PDF → |
| 2026-01-31 | PDF → |
| 2025-12-31 | PDF → |
| 2025-12-31 | PDF → |
| 2025-11-30 | PDF → |
| 2025-11-30 | PDF → |
| 2025-10-31 | PDF → |
| 2025-10-31 | PDF → |
| 2025-09-30 | PDF → |
| 2025-09-30 | PDF → |
| 2025-08-31 | PDF → |
| 2025-08-31 | PDF → |
| 2025-07-31 | PDF → |